Live
- Golden Chariot luxury train to resume operations from Dec 14
- Jain monk Shri 108 Jnaneshwar Muni attains samadhi at Devlapur
- Home minister flags off sports tournament of journalists
- Collector reviews development, welfare programmes in Kalasapadu mandal
- Run for men’s health issues on Nov 23, 24
- Quick commerce workforce expansion to surge by 60 pc in India
- State on the brink of a public uprising over Waqf issue, says BJP
- Dr Soumya Swaminathan to talk on TB, COVID at UoH on Nov 25
- Darshan has not followed interim bail guidelines, Govt tells HC
- Parties keenly await bypoll results, spotlight on high-profile Channapatna
Covaxin only 50% effective against Covid
Covaxin only 50% effective against Covid
Less than initially thought, says Lancet
New Delhi: Covaxin, one of the main vaccines used in India's coronavirus immunization drive, provides only 50% protection against symptomatic Covid-19, according to a real-world study that suggests the shot is less effective than initially thought.
As India was slammed by its second major Covid wave earlier this year, researchers at the All India Institute of Medical Sciences in Delhi analysed data from 2,714 of the hospital's health workers who were showing signs of infection and underwent RT-PCR testing between April 15 and May 15, according to a study published in The Lancet Infectious Diseases journal.
At the start of the country's vaccination campaign in January, staff at AIIMS had exclusively been offered Covaxin, a shot co-developed by India's state-funded health research agency and local company Bharat Biotech International Ltd.
